{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:17:18Z","timestamp":1780561038560,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI155983"],"award-info":[{"award-number":["R01AI155983"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003896","name":"Henry M. Jackson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010463","name":"U.S. Army Medical Department","doi-asserted-by":"publisher","award":["W81XWH-18-2-0040"],"award-info":[{"award-number":["W81XWH-18-2-0040"]}],"id":[{"id":"10.13039\/100010463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ebiom.2023.104815","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T11:53:25Z","timestamp":1696247605000},"page":"104815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7038-2671","authenticated-orcid":false,"given":"Yifan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Merbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Wollen-Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Beckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thembi","family":"Mdluli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Currier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letzibeth","family":"Mendez-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Dussupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly J.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"De La Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson L.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1407-3414","authenticated-orcid":false,"given":"Dominic","family":"Paquin-Proulx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3905-4877","authenticated-orcid":false,"given":"Michael A.","family":"Eller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Koren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayvon","family":"Modjarrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3650-8490","authenticated-orcid":false,"given":"Morgane","family":"Rolland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ebiom.2023.104815_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus. I. Isolations and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"24","key":"10.1016\/j.ebiom.2023.104815_bib2","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","article-title":"Zika virus outbreak on yap island, federated states of Micronesia","volume":"360","author":"Duffy","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104815_bib3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3201\/eid2006.140138","article-title":"Zika virus, French polynesia, South pacific, 2013","volume":"20","author":"Cao-Lormeau","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104815_bib4","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.3201\/eid2110.150847","article-title":"Zika virus outbreak, bahia, Brazil","volume":"21","author":"Campos","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"16","key":"10.1016\/j.ebiom.2023.104815_bib5","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1602113","article-title":"Zika virus","volume":"374","author":"Petersen","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.ebiom.2023.104815_bib6","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMc1604449","article-title":"Evidence of sexual\u00a0transmission of zika virus","volume":"374","author":"D'Ortenzio","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.ebiom.2023.104815_bib7","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1056\/NEJMoa1601824","article-title":"Zika virus infection with prolonged maternal viremia and fetal brain abnormalities","volume":"374","author":"Driggers","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"10033","key":"10.1016\/j.ebiom.2023.104815_bib8","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(16)00651-6","article-title":"Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study","volume":"387","author":"Cauchemez","year":"2016","journal-title":"Lancet"},{"issue":"10120","key":"10.1016\/j.ebiom.2023.104815_bib9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials","volume":"391","author":"Gaudinski","year":"2018","journal-title":"Lancet"},{"issue":"10120","key":"10.1016\/j.ebiom.2023.104815_bib10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","article-title":"Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials","volume":"391","author":"Modjarrad","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104815_bib11","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1473-3099(20)30085-2","article-title":"Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial","volume":"20","author":"Stephenson","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104815_bib12","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S1473-3099(20)30733-7","article-title":"Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in healthy adults: an observer-blind, randomised, phase 1 trial","volume":"21","author":"Han","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104815_bib13","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1056\/NEJMoa1708120","article-title":"Safety and immunogenicity of an anti-zika virus DNA vaccine","volume":"385","author":"Tebas","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.ebiom.2023.104815_bib14","first-page":"00192","article-title":"Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial","volume":"S1473-3099","author":"Koren","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104815_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41591-019-0746-2","article-title":"Potent Zika and\u00a0dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor","volume":"26","author":"Dussupt","year":"2020","journal-title":"Nat Med"},{"issue":"14","key":"10.1016\/j.ebiom.2023.104815_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aan6809","article-title":"Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors","volume":"2","author":"Rogers","year":"2017","journal-title":"Sci Immunol"},{"issue":"6427","key":"10.1016\/j.ebiom.2023.104815_bib17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1126\/science.aav6618","article-title":"Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region","volume":"363","author":"Rodriguez-Barraquer","year":"2019","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104815_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002726","article-title":"Prior dengue virus infection and risk of Zika: a pediatric cohort in Nicaragua","volume":"16","author":"Gordon","year":"2019","journal-title":"PLoS Med"},{"issue":"7749","key":"10.1016\/j.ebiom.2023.104815_bib19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/d41586-019-00868-6","article-title":"Effects of dengue immunity on Zika virus infection","volume":"567","author":"Whitehead","year":"2019","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104815_bib20","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/infdis\/jiab185","article-title":"Limited flavivirus cross-reactive antibody responses elicited by a zika virus deoxyribonucleic acid vaccine candidate in humans","volume":"224","author":"Burgomaster","year":"2021","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104815_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008034","article-title":"Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans","volume":"14","author":"Malafa","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104815_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009101","article-title":"RV144 HIV-1 vaccination impacts post-infection antibody responses","volume":"16","author":"Mdluli","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2023.104815_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2020.112874","article-title":"A\u00a0high-throughput multiplex assay to characterize flavivirus-specific immunoglobulins","volume":"487","author":"Merbah","year":"2020","journal-title":"J\u00a0Immunol Methods"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104815_bib24","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.3201\/eid2811.221041","article-title":"Coronavirus antibody responses before COVID-19 pandemic, Africa and Thailand","volume":"28","author":"Li","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"6304","key":"10.1016\/j.ebiom.2023.104815_bib25","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science"},{"issue":"7617","key":"10.1016\/j.ebiom.2023.104815_bib26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature"},{"issue":"1-2","key":"10.1016\/j.ebiom.2023.104815_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.016","article-title":"A\u00a0robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples","volume":"366","author":"Ackerman","year":"2011","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.ebiom.2023.104815_bib28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jim.2018.08.012","article-title":"A\u00a0flow cytometry based assay that simultaneously measures cytotoxicity and monocyte mediated antibody dependent effector activity","volume":"462","author":"Alrubayyi","year":"2018","journal-title":"J\u00a0Immunol Methods"},{"issue":"20","key":"10.1016\/j.ebiom.2023.104815_bib29","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.vaccine.2019.04.013","article-title":"Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice","volume":"37","author":"Lecouturier","year":"2019","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104815_bib30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/infdis\/148.6.1055","article-title":"Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune status","volume":"148","author":"Scott","year":"1983","journal-title":"J\u00a0Infect Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104815_bib31","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3201\/eid1408.080287","article-title":"Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007","volume":"14","author":"Lanciotti","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"6301","key":"10.1016\/j.ebiom.2023.104815_bib32","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"issue":"suppl_10","key":"10.1016\/j.ebiom.2023.104815_bib33","doi-asserted-by":"crossref","first-page":"S906","DOI":"10.1093\/infdis\/jix513","article-title":"Humoral immune responses against zika virus infection and the importance of preexisting flavivirus immunity","volume":"216","author":"Priyamvada","year":"2017","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104815_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/cix732","article-title":"Innate, T-, and B-cell responses in acute human zika patients","volume":"66","author":"Lai","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2023.104815_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijid.2019.01.023","article-title":"Evaluation of serological cross-reactivity between yellow fever and other flaviviruses","volume":"81","author":"Souza","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ebiom.2023.104815_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41541-019-0133-5","article-title":"Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccination","volume":"4","author":"Bradt","year":"2019","journal-title":"NPJ Vaccines"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104815_bib37","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/infdis\/jiz592","volume":"221","author":"Glass","year":"2020","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104815_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009673","article-title":"Impact of prior Dengue immunity on Zika vaccine protection in rhesus macaques and mice","volume":"17","author":"Larocca","year":"2021","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104815_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chom.2008.08.004","article-title":"Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development","volume":"4","author":"Pierson","year":"2008","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104815_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/v11010019","article-title":"Pre-existing dengue immunity drives a DENV-biased plasmablast response in ZIKV-infected patient","volume":"11","author":"Bhaumik","year":"2018","journal-title":"Viruses"},{"issue":"614","key":"10.1016\/j.ebiom.2023.104815_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg9478","article-title":"Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term","volume":"13","author":"Katzelnick","year":"2021","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104815_bib42","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4269\/ajtmh.19-0738","article-title":"Safety and immunogenicity of an AS03(B)-Adjuvanted inactivated tetravalent dengue virus vaccine administered on varying schedules to healthy U.S. Adults: a phase 1\/2 randomized study","volume":"103","author":"Lin","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104815_bib43","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol"},{"issue":"6334","key":"10.1016\/j.ebiom.2023.104815_bib44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"issue":"6507","key":"10.1016\/j.ebiom.2023.104815_bib45","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.abb6143","article-title":"Zika virus infection enhances future risk of severe dengue disease","volume":"369","author":"Katzelnick","year":"2020","journal-title":"Science"},{"issue":"9599","key":"10.1016\/j.ebiom.2023.104815_bib46","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue","volume":"370","author":"Halstead","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2023.104815_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.640190","article-title":"Pre-existing immunity to Japanese encephalitis virus alters CD4 T cell responses to zika virus inactivated vaccine","volume":"12","author":"Lima","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104815_bib48","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/imr.12503","article-title":"Systems serology for evaluation of HIV vaccine trials","volume":"275","author":"Ackerman","year":"2017","journal-title":"Immunol Rev"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642300381X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642300381X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:28:44Z","timestamp":1762457324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642300381X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":48,"alternative-id":["S235239642300381X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104815","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Henry M Jackson Foundation for the Advancement of Military Medicine, Inc. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104815"}}